Methodological advances: The unsung heroes of the GPCR structural revolution

Nature Reviews Molecular Cell Biology

Volumn 16, Issue 2, 2015, Pages 69-81

  Ghosh, Eshan ^a   Kumari, Punita ^a   Jaiman, Deepika ^a   Shukla, Arun K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; G PROTEIN COUPLED RECEPTOR; LIPID; RECOMBINANT PROTEIN;

CRYSTAL STRUCTURE; CRYSTALLIZATION; HUMAN GENOME; MOLECULAR EVOLUTION; PRIORITY JOURNAL; PROTEIN ENGINEERING; RECEPTOR SOLUBILIZATION; REVIEW; SIGNAL TRANSDUCTION; SYNCHROTRON; TECHNOLOGY; THERMOSTABILITY; ANIMAL; CHEMISTRY; GENETICS; HUMAN; PROCEDURES; PROTEIN CONFORMATION;

ANIMALS; HUMANS; PROTEIN CONFORMATION; PROTEIN ENGINEERING; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84923141629     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3933     Document Type: Review

References (121)

1. Pierce, K. L., Premont, R. T. & Lefkowitz, R. J. Seven-transmembrane receptors. Nature Rev. Mol. Cell Biol. 3, 639-650 (2002).
2. Bockaert, J. & Pin, J. P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18, 1723-1729 (1999).
3. Lagerstrom, M. C. & Schioth, H. B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nature Rev. Drug Discov. 7, 339-357 (2008).
4. Foord, S. M. et al. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol. Rev. 57, 279-288 (2005).
5. Conn, P. M., Ulloa-Aguirre, A., Ito, J. & Janovick, J. A. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol. Rev. 59, 225-250 (2007).
6. Ma, P. & Zemmel, R. Value of novelty? Nature Rev. Drug Discov. 1, 571-572 (2002).
7. Zalewska, M., Siara, M. & Sajewicz, W. G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy. Acta Poloniae Pharmaceut. 71, 229-243 (2014).
8. Reiter, E., Ahn, S., Shukla, A. K. & Lefkowitz, R. J. Molecular mechanism of α-Arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 52, 179-197 (2012).
9. Reiter, E. & Lefkowitz, R. J. GRKs and α-Arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol. Metabolism 17, 159-165 (2006).
10. Deupi, X., Standfuss, J. & Schertler, G. Conserved activation pathways in G-protein-coupled receptors. Biochem. Soc. Trans. 40, 383-388 (2012).
11. Kang, D. S., Tian, X. & Benovic, J. L. Role of α-Arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr. Opin. Cell Biol. 27, 63-71 (2014).
12. Tian, X., Kang, D. S. & Benovic, J. L. α-Arrestins and G protein-coupled receptor trafficking. Handb. Exp. Pharmacol. 219, 173-186 (2014).
13. Hall, R. A., Premont, R. T. & Lefkowitz, R. J. Heptahelical receptor signaling: beyond the G protein paradigm. J. Cell Biol. 145, 927-932 (1999).
14. Lefkowitz, R. J. Seven transmembrane receptors: something old, something new. Acta Physiol. 190, 9-19 (2007).
15. Goodman, O. B. Jr. et al. α-Arrestin acts as a clathrin adaptor in endocytosis of the 2-Adrenergic receptor. Nature 383, 447-450 (1996).
16. Shukla, A. K., Xiao, K. & Lefkowitz, R. J. Emerging paradigms of α-Arrestin-dependent seven transmembrane receptor signaling. Trends Biochem. Sci. 36, 457-469 (2011).
17. Shukla, A. K. Biasing GPCR signaling from inside. Sci. Signal. 7, pe3 (2014).
18. DeWire, S. M., Ahn, S., Lefkowitz, R. J. & Shenoy, S. K. α-Arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510 (2007).
19. Rasmussen, S. G. et al. Crystal structure of the human 2 adrenergic G-protein-coupled receptor. Nature 450, 383-387 (2007).
20. Katritch, V., Cherezov, V. & Stevens, R. C. Structure-function of the G protein-coupled receptor superfamily. Annu. Rev. Pharmacol. Toxicol. 53, 531-556 (2013).
21. Rasmussen, S. G. et al. Crystal structure of the 2 adrenergic receptor-Gs protein complex. Nature 477, 549-555 (2011).
22. Shukla, A. K. et al. Visualization of arrestin recruitment by a G-protein-coupled receptor. Nature 512, 218-222 (2014).
23. Shukla, A. K. et al. Structure of active α-Arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497, 137-141 (2013).
24. Lundstrom, K. et al. Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems. J. Struct. Funct. Genom. 7, 77-91 (2006).
25. Roy, A., Shukla, A. K., Haase, W. & Michel, H. Employing Rhodobacter sphaeroides to functionally express and purify human G protein-coupled receptors. Biol. Chem. 389, 69-78 (2008).
26. Shukla, A. K., Haase, W., Reinhart, C. & Michel, H. Heterologous expression and comparative characterization of the human neuromedin U subtype II receptor using the methylotrophic yeast Pichia pastoris and mammalian cells. Int. J. Biochem. Cell Biol. 39, 931-942 (2007).
27. Shukla, A. K., Haase, W., Reinhart, C. & Michel, H. Heterologous expression and characterization of the recombinant bradykinin B2 receptor using the methylotrophic yeast Pichia pastoris. Protein Expression Purif. 55, 1-8 (2007).
28. Shukla, A. K., Haase, W., Reinhart, C. & Michel, H. Functional overexpression and characterization of human bradykinin subtype 2 receptor in insect cells using the baculovirus system. J. Cell. Biochem. 99, 868-877 (2006).
29. Shukla, A. K., Reinhart, C. & Michel, H. Dimethylsulphoxide as a tool to increase functional expression of heterologously produced GPCRs in mammalian cells. FEBS Lett. 580, 4261-4265 (2006).
30. Shukla, A. K., Haase, W., Reinhart, C. & Michel, H. Biochemical and pharmacological characterization of the human bradykinin subtype 2 receptor produced in mammalian cells using the Semliki Forest virus system. Biol. Chem. 387, 569-576 (2006).
31. Shukla, A. K., Reinhart, C. & Michel, H. Comparative analysis of the human angiotensin II type 1a receptor heterologously produced in insect cells and mammalian cells. Biochem. Biophys. Res. Commun. 349, 6-14 (2006).
32. Cherezov, V. et al. High-resolution crystal structure of an engineered human 2-Adrenergic G protein-coupled receptor. Science 318, 1258-1265 (2007).
33. Shimamura, T. et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 475, 65-70 (2011).
34. Egloff, P. et al. Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli. Proc. Natl Acad. Sci. USA 111, E655-E662 (2014).
35. Chelikani, P., Reeves, P. J., Rajbhandary, U. L. & Khorana, H. G. The synthesis and high-level expression of a 2-Adrenergic receptor gene in a tetracycline-inducible stable mammalian cell line. Protein Sci.: Publ. Protein Soc. 15, 1433-1440 (2006).
36. Cook, B. L., Ernberg, K. E., Chung, H. & Zhang, S. Study of a synthetic human olfactory receptor 17-4: expression and purification from an inducible mammalian cell line. PloS one 3, e2920 (2008).
37. Wang, X. & Zhang, S. Production of a bioengineered G-protein coupled receptor of human formyl peptide receptor 3. PloS one 6, e23076 (2011).
38. Standfuss, J. et al. Crystal structure of a thermally stable rhodopsin mutant. J. Mol. Biol. 372, 1179-1188 (2007).
39. Andre, N. et al. Enhancing functional production of G protein-coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen. Protein Sci. 15, 1115-1126 (2006).
40. Kobilka, B. K. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal. Biochem. 231, 269-271 (1995).
41. Gether, U. et al. Agonists induce conformational changes in transmembrane domains III and VI of the 2 adrenoceptor. EMBO J. 16, 6737-6747 (1997).
42. Kobilka, B. K. & Gether, U. Use of fluorescence spectroscopy to study conformational changes in the 2-Adrenoceptor. Methods Enzymol. 343, 170-182 (2002).
43. Day, P. W. et al. A monoclonal antibody for G protein-coupled receptor crystallography. Nature Methods 4, 927-929 (2007).
44. Ostermeier, C., Iwata, S., Ludwig, B. & Michel, H. Fv fragment-mediated crystallization of the membrane protein bacterial cytochrome c oxidase. Nature Struct. Biol. 2, 842-846 (1995).
45. Hunte, C., Koepke, J., Lange, C., Rossmanith, T. & Michel, H. Structure at 2.3 A resolution of the cytochrome bc(1) complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Structure 8, 669-684 (2000).
46. Padan, E., Venturi, M., Michel, H. & Hunte, C. Production and characterization of monoclonal antibodies directed against native epitopes of NhaA, the Na+/H+ antiporter of Escherichia coli. FEBS Lett. 441, 53-58 (1998).
47. Hunte, C. & Michel, H. Crystallisation of membrane proteins mediated by antibody fragments. Curr. Opin. Struct. Biol. 12, 503-508 (2002).
48. Screpanti, E., Padan, E., Rimon, A., Michel, H. & Hunte, C. Crucial steps in the structure determination of the Na+/H+ antiporter NhaA in its native conformation. J. Mol. Biol. 362, 192-202 (2006).
49. Hino, T. et al. G-protein-coupled receptor inactivation by an allosteric inverse-Agonist antibody. Nature 482, 237-240 (2012).
50. Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into 2-Adrenergic receptor function. Science 318, 1266-1273 (2007).
51. Haga, K. et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482, 547-551 (2012).
52. Kruse, A. C. et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482, 552-556 (2012).
53. Manglik, A. et al. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 485, 321-326 (2012).
54. Zhang, C. et al. High-resolution crystal structure of human protease-Activated receptor 1. Nature 492, 387-392 (2012).
55. Granier, S. et al. Structure of the delta-opioid receptor bound to naltrindole. Nature 485, 400-404 (2012).
56. Jaakola, V. P. et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211-1217 (2008).
57. Chien, E. Y. et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330, 1091-1095 (2010).
58. Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071 (2010).
59. Thompson, A. A. et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 485, 395-399 (2012).
60. Wu, H. et al. Structure of the human α-opioid receptor in complex with JDTic. Nature 485, 327-332 (2012).
61. Siu, F. Y. et al. Structure of the human glucagon class B G-protein-coupled receptor. Nature 499, 444-449 (2013).
62. Dore, A. S. et al. Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature 511, 557-562 (2014).
63. Hollenstein, K. et al. Structure of class B GPCR corticotropin-releasing factor receptor 1. Nature 499, 438-443 (2013).
64. Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851-855 (2012).
65. Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967-976 (2012).
66. Liu, W. et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337, 232-236 (2012).
67. Tan, Q. et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science 341, 1387-1390 (2013).
68. Zou, Y., Weis, W. I. & Kobilka, B. K. N-terminal T4 lysozyme fusion facilitates crystallization of a G protein coupled receptor. PloS one 7, e46039 (2012).
69. Warne, T., Serrano-Vega, M. J., Tate, C. G. & Schertler, G. F. Development and crystallization of a minimal thermostabilised G protein-coupled receptor. Protein Expression Purif. 65, 204-213 (2009).
70. Warne, T. et al. Structure of a 1-Adrenergic G-protein-coupled receptor. Nature 454, 486-491 (2008).
71. Tate, C. G. & Schertler, G. F. Engineering G protein-coupled receptors to facilitate their structure determination. Curr. Opin. Struct. Biol. 19, 386-395 (2009).
72. Dore, A. S. et al. Structure of the adenosine A2A receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 19, 1283-1293 (2011).
73. Srivastava, A. et al. High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875. Nature 513, 124-127 (2014).
74. White, J. F. et al. Structure of the agonist-bound neurotensin receptor. Nature 490, 508-513 (2012).
75. Hanson, M. A. et al. A specific cholesterol binding site is established by the 2.8 A structure of the human 2-Adrenergic receptor. Structure 16, 897-905 (2008).
76. Thompson, A. A. et al. GPCR stabilization using the bicelle-like architecture of mixed sterol-detergent micelles. Methods 55, 310-317 (2011).
77. Chae, P. S. et al. Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nature Methods 7, 1003-1008 (2010).
78. Chae, P. S. et al. Glucose-neopentyl glycol (GNG) amphiphiles for membrane protein study. Chem. Commun. 49, 2287-2289 (2013).
79. Chae, P. S. et al. Novel tripod amphiphiles for membrane protein analysis. Chemistry 19, 15645-15651 (2013).
80. Lee, S. C. et al. Steroid-based facial amphiphiles for stabilization and crystallization of membrane proteins. Proc. Natl Acad. Sci. USA 110, E1203-E1211 (2013).
81. Tao, H. et al. Synthesis and properties of dodecyl trehaloside detergents for membrane protein studies. Langmuir. 28, 11173-11181 (2012).
82. Caron, M. G., Srinivasan, Y., Pitha, J., Kociolek, K. & Lefkowitz, R. J. Affinity chromatography of the α-Adrenergic receptor. J. Biol. Chem. 254, 2923-2927 (1979).
83. Lefkowitz, R. J., Sun, J. P. & Shukla, A. K. A crystal clear view of the 2-Adrenergic receptor. Nature Biotech. 26, 189-191 (2008).
84. Shukla, A. K., Sun, J. P. & Lefkowitz, R. J. Crystallizing thinking about the 2-Adrenergic receptor. Mol. Pharmacol. 73, 1333-1338 (2008).
85. Rosenbaum, D. M. et al. Structure and function of an irreversible agonist-2 adrenoceptor complex. Nature 469, 236-240 (2011).
86. Rasmussen, S. G. et al. Structure of a nanobody-stabilized active state of the 2 adrenoceptor. Nature 469, 175-180 (2011).
87. Weichert, D. et al. Covalent agonists for studying G protein-coupled receptor activation. Proc. Natl Acad. Sci. USA 111, 10744-10748 (2014).
88. Huang, J., Chen, S., Zhang, J. J. & Huang, X. Y. Crystal structure of oligomeric 1-Adrenergic G protein-coupled receptors in ligand-free basal state. Nature Struct. Mol. Biol. 20, 419-425 (2013).
89. Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H. W. & Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183-187 (2008).
90. Faham, S. & Bowie, J. U. Bicelle crystallization: a new method for crystallizing membrane proteins yields a monomeric bacteriorhodopsin structure. J. Mol. Biol. 316, 1-6 (2002).
91. Faham, S. et al. Crystallization of bacteriorhodopsin from bicelle formulations at room temperature. Protein Sci. 14, 836-840 (2005).
92. Cherezov, V., Peddi, A., Muthusubramaniam, L., Zheng, Y. F. & Caffrey, M. A robotic system for crystallizing membrane and soluble proteins in lipidic mesophases. Acta Crystallogr. D Biol. Crystallogr. 60, 1795-1807 (2004).
93. Misquitta, L. V. et al. Membrane protein crystallization in lipidic mesophases with tailored bilayers. Structure 12, 2113-2124 (2004).
94. Cherezov, V., Clogston, J., Papiz, M. Z. & Caffrey, M. Room to move: crystallizing membrane proteins in swollen lipidic mesophases. J. Mol. Biol. 357, 1605-1618 (2006).
95. Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protoc. 4, 706-731 (2009).
96. Nollert, P., Qiu, H., Caffrey, M., Rosenbusch, J. P. & Landau, E. M. Molecular mechanism for the crystallization of bacteriorhodopsin in lipidic cubic phases. FEBS Lett. 504, 179-186 (2001).
97. Rummel, G. et al. Lipidic cubic phases: new matrices for the three-dimensional crystallization of membrane proteins. J. Struct. Biol. 121, 82-91 (1998).
98. Chiu, M. L. et al. Crystallization in cubo: general applicability to membrane proteins. Acta Crystallogr. D Biol. Crystallogr. 56, 781-784 (2000).
99. Landau, E. M. & Rosenbusch, J. P. Lipidic cubic phases: a novel concept for the crystallization of membrane proteins. Proc. Natl Acad. Sci. USA 93, 14532-14535 (1996).
100. Pebay-Peyroula, E., Rummel, G., Rosenbusch, J. P. & Landau, E. M. X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. Science 277, 1676-1681 (1997).
101. Cherezov, V. et al. Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 microm size X-ray synchrotron beam. J. R. Soc. Interface 6, S587-S597 (2009).
102. Cherezov, V., Liu, J., Griffith, M., Hanson, M. A. & Stevens, R. C. LCP-FRAP assay for pre-screening membrane proteins for in meso crystallization. Crystal Growth Design 8, 4307-4315 (2008).
103. Liu, W., Hanson, M. A., Stevens, R. C. & Cherezov, V. LCP-Tm: an assay to measure and understand stability of membrane proteins in a membrane environment. Biophys. J. 98, 1539-1548 (2010).
104. Xu, F., Liu, W., Hanson, M. A., Stevens, R. C. & Cherezov, V. Development of an automated high throughput LCP-FRAP assay to guide membrane protein crystallization in lipid mesophases. Crystal Growth Design 11, 1193-1201 (2011).
105. Chapman, H. N. et al. Femtosecond X-ray protein nanocrystallography. Nature 470, 73-77 (2011).
106. Weierstall, U. et al. Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography. Nature Commun. 5, 3309 (2014).
107. Liu, W. et al. Serial femtosecond crystallography of G protein-coupled receptors. Science 342, 1521-1524 (2013).
108. Liu, W., Ishchenko, A. & Cherezov, V. Preparation of microcrystals in lipidic cubic phase for serial femtosecond crystallography. Nature Protoc. 9, 2123-2134 (2014).
109. Bokoch, M. P. et al. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 463, 108-112 (2010).
110. Yao, X. et al. Coupling ligand structure to specific conformational switches in the 2-Adrenoceptor. Nature Chem. Biol. 2, 417-422 (2006).
111. Pardon, E. et al. A general protocol for the generation of Nanobodies for structural biology. Nature Protoc. 9, 674-693 (2014).
112. Steyaert, J. & Kobilka, B. K. Nanobody stabilization of G protein-coupled receptor conformational states. Curr. Opin. Struct. Biol. 21, 567-572 (2011).
113. Kruse, A. C. et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504, 101-106 (2013).
114. Ring, A. M. et al. Adrenaline-Activated structure of 2-Adrenoceptor stabilized by an engineered nanobody. Nature 502, 575-579 (2013).
115. Shukla, A. K. et al. Distinct conformational changes in α-Arrestin report biased agonism at seven-transmembrane receptors. Proc. Natl Acad. Sci. USA 105, 9988-9993 (2008).
116. Westfield, G. H. et al. Structural flexibility of the G?s α-helical domain in the 2-Adrenoceptor Gs complex. Proc. Natl Acad. Sci. USA 108, 16086-16091 (2011).
117. Chung, K. Y. et al. Conformational changes in the G protein Gs induced by the 2 adrenergic receptor. Nature 477, 611-615 (2011).
118. Gurevich, V. V. & Gurevich, E. V. The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol. Ther. 110, 465-502 (2006).
119. Gurevich, V. V. & Gurevich, E. V. The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci. 25, 105-111 (2004).
120. Gurevich, V. V. & Gurevich, E. V. Structural determinants of arrestin functions. Progress Mol. Biol. Translat. Sci. 118, 57-92 (2013).
121. Szczepek, M. et al. Crystal structure of a common GPCR-binding interface for G protein and arrestin. Nature Commun. 5, 4801 (2014).